Literature DB >> 8666388

A novel PCR technique using Alu-specific primers to identify unknown flanking sequences from the human genome.

M Minami1, K Poussin, C Bréchot, P Paterlini.   

Abstract

The rapid and reproducible identification of new cellular DNA sequences adjacent to known sequences is difficult to achieve with the currently available procedures. Here we describe a novel approach based on the polymerase chain reaction (PCR) using a primer specific to the known sequence and another directed to a human Alu repeat. To avoid undesirable amplifications between Alu sequences, primers are constructed with dUTPs and destroyed by uracil DNA glycosylase treatment after 10 initial cycles of amplification. Only desirable fragments are then further amplified with specific primers to the known region and to a tag sequence introduced in the Alu-specific primer. Using this protocol, we have successfully identified cellular sequences flanking integrated hepatitis B virus DNA from the human genome of three hepatoma tissues. The method enables a direct specific amplification without any ligation or nonspecific annealing steps as required by previous PCR-based protocols. This rapid and straightforward approach will be a powerful tool for the study of viral integration sites, but is also widely applicable to other studies of the human genome.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8666388     DOI: 10.1006/geno.1995.9004

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  23 in total

Review 1.  Update of research and management of hepatitis B.

Authors:  Takeshi Okanoue; Masahito Minami
Journal:  J Gastroenterol       Date:  2006-02       Impact factor: 7.527

2.  Flanking-sequence exponential anchored-polymerase chain reaction amplification: a sensitive and highly specific method for detecting retroviral integrant-host-junction sequences.

Authors:  M A Pule; A Rousseau; J Vera; H E Heslop; M K Brenner; E F Vanin
Journal:  Cytotherapy       Date:  2008       Impact factor: 5.414

3.  A rapid RT-PCR based method to isolate complementary DNA fragments flanking retrovirus integration sites.

Authors:  P J Valk; M Joosten; Y Vankan; B Löwenberg; R Delwel
Journal:  Nucleic Acids Res       Date:  1997-11-01       Impact factor: 16.971

4.  No evidence of infectious retroviruses in measles virus vaccines produced in chicken embryo cell cultures.

Authors:  M Shahabuddin; J F Sears; A S Khan
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

5.  HIV reproducibly establishes a latent infection after acute infection of T cells in vitro.

Authors:  Albert Jordan; Dwayne Bisgrove; Eric Verdin
Journal:  EMBO J       Date:  2003-04-15       Impact factor: 11.598

6.  Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas.

Authors:  Y Murakami; K Saigo; H Takashima; M Minami; T Okanoue; C Bréchot; P Paterlini-Bréchot
Journal:  Gut       Date:  2005-08       Impact factor: 23.059

7.  Adeno-associated virus vector-mediated transgene integration into neurons and other nondividing cell targets.

Authors:  P Wu; M I Phillips; J Bui; E F Terwilliger
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

8.  Endogenous non-retroviral RNA virus elements in mammalian genomes.

Authors:  Masayuki Horie; Tomoyuki Honda; Yoshiyuki Suzuki; Yuki Kobayashi; Takuji Daito; Tatsuo Oshida; Kazuyoshi Ikuta; Patric Jern; Takashi Gojobori; John M Coffin; Keizo Tomonaga
Journal:  Nature       Date:  2010-01-07       Impact factor: 49.962

9.  Inheritance of DNA transferred from American trypanosomes to human hosts.

Authors:  Mariana M Hecht; Nadjar Nitz; Perla F Araujo; Alessandro O Sousa; Ana de Cássia Rosa; Dawidson A Gomes; Eduardo Leonardecz; Antonio R L Teixeira
Journal:  PLoS One       Date:  2010-02-12       Impact factor: 3.240

10.  Novel endogenous retrovirus in rabbits previously reported as human retrovirus 5.

Authors:  David J Griffiths; Cécile Voisset; Patrick J W Venables; Robin A Weiss
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.